QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
QQQ   272.48 (+1.86%)
AAPL   111.81 (+1.57%)
MSFT   207.42 (+2.41%)
FB   254.75 (+2.66%)
GOOGL   1,459.82 (+2.08%)
AMZN   3,128.99 (+5.69%)
NVDA   505.51 (+0.96%)
TSLA   424.23 (-5.60%)
BABA   275.29 (+0.54%)
CGC   16.04 (+1.91%)
GE   6.25 (-1.57%)
MU   49.70 (+1.12%)
AMD   77.70 (-0.31%)
T   28.51 (-0.42%)
F   6.78 (-1.31%)
ACB   7.32 (+15.82%)
GILD   63.40 (-1.26%)
NFLX   491.17 (+0.78%)
DIS   127.21 (+1.44%)
BAC   23.94 (-2.17%)
BA   156.80 (+0.29%)
Log in
NASDAQ:LIVN

LivaNova Stock Forecast, Price & News

$42.50
-1.42 (-3.23 %)
(As of 09/22/2020 12:00 AM ET)
Add
Compare
Today's Range
$42.42
Now: $42.50
$44.17
50-Day Range
$43.92
MA: $46.35
$48.82
52-Week Range
$33.40
Now: $42.50
$85.30
Volume506,126 shs
Average Volume567,872 shs
Market Capitalization$2.07 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.87
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV”) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygenators, perfusion tubing sets, cannulae, and accessories, as well as related equipment and disposables for autotransfusion and autologous blood washing for neonatal, pediatric, and adult patients. It also provides surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves, such as self-anchoring tissue heart, tissue heart, and mechanical heart valves, as well as heart valve repair products; and temporary extracorporeal cardiopulmonary life support solutions for critically ill patients. The NM segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, treatment-resistant depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company was founded in 1987 and is headquartered in London, the United Kingdom.
Read More
LivaNova logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.81 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LIVN
CUSIPN/A
Phone44-0-20-3325-0660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.08 billion
Cash Flow$5.35 per share
Book Value$28.59 per share

Profitability

Net Income$-155,180,000.00

Miscellaneous

Employees4,000
Market Cap$2.07 billion
Next Earnings Date11/4/2020 (Estimated)
OptionableOptionable
$42.50
-1.42 (-3.23 %)
(As of 09/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LIVN News and Ratings via Email

Sign-up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











LivaNova (NASDAQ:LIVN) Frequently Asked Questions

How has LivaNova's stock been impacted by Coronavirus?

LivaNova's stock was trading at $62.65 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LIVN shares have decreased by 32.2% and is now trading at $42.50.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of LivaNova?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LivaNova in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for LivaNova
.

When is LivaNova's next earnings date?

LivaNova is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for LivaNova
.

How were LivaNova's earnings last quarter?

LivaNova PLC (NASDAQ:LIVN) issued its quarterly earnings data on Wednesday, July, 29th. The company reported ($0.15) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.30) by $0.15. The firm had revenue of $182.20 million for the quarter, compared to analyst estimates of $169.74 million. LivaNova had a positive return on equity of 7.00% and a negative net margin of 16.47%. The firm's revenue was down 34.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.70 earnings per share.
View LivaNova's earnings history
.

What guidance has LivaNova issued on next quarter's earnings?

LivaNova issued an update on its FY20 earnings guidance on Wednesday, July, 29th. The company provided earnings per share guidance of $1.15-1.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.47. The company issued revenue guidance of decline 7-17% yr/yr to $900 million to $1.01 billion, compared to the consensus revenue estimate of $937.94 million.

What price target have analysts set for LIVN?

7 brokers have issued twelve-month target prices for LivaNova's stock. Their forecasts range from $40.00 to $114.00. On average, they anticipate LivaNova's stock price to reach $63.43 in the next twelve months. This suggests a possible upside of 49.2% from the stock's current price.
View analysts' price targets for LivaNova
.

Who are some of LivaNova's key competitors?

What other stocks do shareholders of LivaNova own?

Who are LivaNova's key executives?

LivaNova's management team includes the following people:
  • Mr. Damien McDonald, CEO & Director (Age 54)
  • Mr. Thad Huston, Chief Financial Officer (Age 49)
  • Mr. Douglas J. Manko, Chief Accounting Officer (Age 45)
  • Ms. Keyna Pidcock Skeffington, Gen. Counsel & Sr. VP (Age 56)
  • Mr. David S. Wise, Sr. Advisor (Age 64)

What is LivaNova's stock symbol?

LivaNova trades on the NASDAQ under the ticker symbol "LIVN."

Who are LivaNova's major shareholders?

LivaNova's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.46%), Paradice Investment Management LLC (1.72%), Point72 Asset Management L.P. (1.28%), Federated Hermes Inc. (1.28%), Bank of America Corp DE (1.09%) and Bank of New York Mellon Corp (1.07%). Company insiders that own LivaNova stock include Alfred J Novak, Alistair Simpson, Damien Mcdonald, Daniel Jeffrey Moore, David S Wise, Hugh M Morrison, Thad Allen Huston and William A Kozy.
View institutional ownership trends for LivaNova
.

Which institutional investors are selling LivaNova stock?

LIVN stock was sold by a variety of institutional investors in the last quarter, including Federated Hermes Inc., Goldman Sachs Group Inc., FIL Ltd, Teachers Retirement System of The State of Kentucky, Cubist Systematic Strategies LLC, AQR Capital Management LLC, Jacobs Levy Equity Management Inc., and Prudential Financial Inc.. Company insiders that have sold LivaNova company stock in the last year include Damien Mcdonald, and Daniel Jeffrey Moore.
View insider buying and selling activity for LivaNova
.

Which institutional investors are buying LivaNova stock?

LIVN stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Marshall Wace LLP, Hudson Bay Capital Management LP, Diamond Hill Capital Management Inc., Brandes Investment Partners LP, KEYWISE CAPITAL MANAGEMENT HK Ltd, Bank of America Corp DE, and Nuveen Asset Management LLC. Company insiders that have bought LivaNova stock in the last two years include Alfred J Novak, and William A Kozy.
View insider buying and selling activity for LivaNova
.

How do I buy shares of LivaNova?

Shares of LIVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is LivaNova's stock price today?

One share of LIVN stock can currently be purchased for approximately $42.50.

How big of a company is LivaNova?

LivaNova has a market capitalization of $2.07 billion and generates $1.08 billion in revenue each year. The company earns $-155,180,000.00 in net income (profit) each year or $3.08 on an earnings per share basis. LivaNova employs 4,000 workers across the globe.

What is LivaNova's official website?

The official website for LivaNova is www.livanova.com.

How can I contact LivaNova?

LivaNova's mailing address is 20 EASTBOURNE TERRACE, LONDON X0, W2 6LG. The company can be reached via phone at 44-0-20-3325-0660 or via email at [email protected]

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.